MAPT and Alzheimer disease: The level of hippocampal Tau phosphorylation in 3xTg-AD mice, and its subsequent attenuation after the treatment correspond to the level and activation of GSK-3β and PP2A, as the main Tau kinase and phosphatase, respectively (Fig. 8).